Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: An open-label, noncomparative study

British Journal of Dermatology

Volumn 161, Issue 4, 2009, Pages 904-909

  Saiag, P ^a   Bauhofer, A ^b   Bouscarat, F ^c   Aquilina, C ^d   Ortonne, J P ^e   Dupin, N ^f   Mougin, C ^g  

^a HÔPITAL AMBROISE PARÉ   (France)

^b VIATRIS GmbH and Co KG   (Germany)

^c BICHAT HOSPITAL   (France)

^d Serv Univ Psychiat l'Enfant l'A   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f Université René Descartes ^*  (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Anogenital warts; Highly active antiretroviral therapy; Human immunodeficiency virus; Human papillomavirus; Imiquimod

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; IMIQUIMOD; VIRUS DNA;

ADULT; APPLICATION SITE BURNING; APPLICATION SITE PIGMENTATION CHANGE; ARTICLE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; DRUG EFFICACY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INSOMNIA; MALE; PAIN; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SKIN ULCER; SUPRAPUBIC PAIN; TREATMENT DURATION; VIRUS LOAD; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINOQUINOLINES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS DISEASES; CONDYLOMATA ACUMINATA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69549100799     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09210.x     Document Type: Article

References (28)

1. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 527. (Pubitemid 36159887)
2. Aubin F, Pretet JL, Jacquard AC et al. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis 2008 47 : 610 615.
3. Pretet JL, Jacquard AC, Carcopino X et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. Int J Cancer 2008 122 : 428 432. (Pubitemid 350234732)
4. Chirgwin KD, Feldman J, Augenbraun M et al. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis 1995 172 : 235 238.
5. Matorras R, Ariceta JM, Rementeria A et al. Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection. Am J Obstet Gynecol 1991 164 : 42 4.
6. Smith KJ, Skelton HG, Yeager J et al. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). J Am Acad Dermatol 1994 31 : 746 754.
7. Lowy DR, Kirnbauer R, Schiller JT. Genital human papillomavirus infection. Proc Natl Acad Sci USA 1994 91 : 2436 2440.
8. Schiffman M, Castle PE, Jeronimo J et al. Human papillomavirus and cervical cancer. Lancet 2007 370 : 890 907.
9. Kreuter A, Potthoff A, Brockmeyer NH et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol 2008 128 : 2078 2083.
10. Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med 1997 102 : 28 37.
11. Stern PL. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination. J Clin Virol 2005 32 (Suppl. 1 S72 81.
12. Klutke JJ, Bergman A. Interferon as an adjuvant treatment for genital condyloma acuminatum. Int J Gynaecol Obstet 1995 49 : 171 174.
13. Testerman TL, Gerster JF, Imbertson LM et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995 58 : 365 372.
14. Moore RA, Edwards JE, Hopwood J et al. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001 1 : 3.
15. Edwards L, Ferenczy A, Eron L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol 1998 134 : 25 30.
16. Gilson RJ, Shupack JL, Friedman-Kien AE et al. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group. AIDS 1999 13 : 2397 2404.
17. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 1984 2 : 187 193.
18. Cusini M, Salmaso F, Zerboni R et al. 5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy. Int J STD AIDS 2004 15 : 17 20.
19. Sanclemente G, Herrera S, Tyring SK et al. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia. J Eur Acad Dermatol Venereol 2007 21 : 1054 1060.
20. Partridge JM, Hughes JP, Feng Q et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007 196 : 1128 1136.
21. Drobacheff C, Dupont P, Mougin C et al. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse. Eur J Dermatol 2003 13 : 367 371.
22. Dalstein V, Riethmuller D, Pretet JL et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003 106 : 396 403.
23. Pretet JL, Dalstein V, Monnier-Benoit S et al. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women. J Clin Virol 2004 31 : 140 147.
24. Daling JR, Weiss NS, Hislop TG et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987 317 : 973 977.
25. Wieland U, Brockmeyer NH, Weissenborn SJ et al. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 2006 142 : 1438 1444.
26. Tyring SK, Arany I, Stanley MA et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998 178 : 551 555.
27. Scott DR. Eradication of basal cell cancer in an HIV positive patient with topical imiquimod. J Drugs Dermatol 2004 3 : 602.
28. Nunes MG, Trope BM, Cavalcanti SM et al. Bowenoid papulosis in a patient with AIDS treated with imiquimod: case report. Acta Dermatovenerol Croat 2004 12 : 278 281.